Drug
Polyvinyl Alcohol, Povidone
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Eye Pain | 627 | 64.9 | 77.8 | signal |
| 2 | Ocular Discomfort | 101 | 53.0 | 54.5 | signal |
| 3 | Eye Irritation | 447 | 45.7 | 51.8 | signal |
| 4 | Photophobia | 129 | 39.3 | 40.7 | signal |
| 5 | Eye Discharge | 65 | 36.2 | 36.8 | signal |
| 6 | Lacrimation Increased | 150 | 28.5 | 29.7 | signal |
| 7 | Product Use Complaint | 77 | 28.2 | 28.8 | signal |
| 8 | Ocular Hyperaemia | 205 | 24.9 | 26.3 | signal |
| 9 | Dry Eye | 189 | 22.1 | 23.3 | signal |
| 10 | Eye Inflammation | 36 | 21.6 | 21.8 | signal |
| 11 | Eye Swelling | 113 | 17.3 | 17.8 | signal |
| 12 | Eye Pruritus | 94 | 16.1 | 16.5 | signal |
| 13 | Product Administration Error | 55 | 15.6 | 15.8 | signal |
| 14 | Vitreous Floaters | 26 | 15.1 | 15.2 | signal |
| 15 | Cataract | 152 | 14.5 | 15.1 | signal |
| 16 | Eye Infection | 28 | 14.1 | 14.2 | signal |
| 17 | Macular Degeneration | 28 | 13.3 | 13.4 | signal |
| 18 | Intraocular Pressure Increased | 26 | 11.5 | 11.5 | signal |
| 19 | Impaired Quality Of Life | 29 | 11.4 | 11.5 | signal |
| 20 | Ear Discomfort | 19 | 10.5 | 10.6 | signal |
| 21 | Vision Blurred | 249 | 10.3 | 11.0 | signal |
| 22 | Ear Pain | 31 | 9.0 | 9.1 | signal |
| 23 | Eyelid Ptosis | 16 | 8.9 | 8.9 | signal |
| 24 | Eyelid Oedema | 18 | 8.7 | 8.7 | signal |
| 25 | Hospice Care | 15 | 8.6 | 8.6 | signal |
| 26 | Device Use Issue | 25 | 8.2 | 8.2 | signal |
| 27 | Tinnitus | 61 | 7.5 | 7.6 | signal |
| 28 | Eye Disorder | 42 | 7.2 | 7.3 | signal |
| 29 | Seasonal Allergy | 17 | 6.8 | 6.8 | signal |
| 30 | Diplopia | 31 | 6.7 | 6.8 | signal |
| 31 | Blood Urea Increased | 20 | 6.7 | 6.7 | signal |
| 32 | Neutrophil Count Increased | 12 | 6.6 | 6.6 | signal |
| 33 | Visual Acuity Reduced | 38 | 6.4 | 6.5 | signal |
| 34 | Blood Thyroid Stimulating Hormone Increased | 10 | 6.1 | 6.1 | signal |
| 35 | Discomfort | 59 | 5.5 | 5.6 | signal |
| 36 | Disability | 18 | 5.1 | 5.2 | signal |
| 37 | Sneezing | 20 | 5.1 | 5.1 | signal |
| 38 | Visual Impairment | 110 | 5.1 | 5.2 | signal |
| 39 | Glaucoma | 17 | 5.0 | 5.0 | signal |
| 40 | Therapy Interrupted | 59 | 4.8 | 4.9 | signal |
| 41 | Blindness Unilateral | 12 | 4.8 | 4.8 | signal |
| 42 | Rhinorrhoea | 54 | 4.7 | 4.8 | signal |
| 43 | Blindness | 34 | 4.7 | 4.8 | signal |
| 44 | Incorrect Product Storage | 11 | 4.7 | 4.7 | signal |
| 45 | Economic Problem | 12 | 4.4 | 4.4 | signal |
| 46 | Madarosis | 9 | 4.3 | 4.4 | signal |
| 47 | Tenderness | 8 | 4.3 | 4.3 | signal |
| 48 | Retinal Detachment | 7 | 4.3 | 4.3 | signal |
| 49 | Sinus Disorder | 15 | 4.3 | 4.3 | signal |
| 50 | Hyperlipidaemia | 9 | 4.2 | 4.3 | signal |
| 51 | Eye Haemorrhage | 10 | 4.2 | 4.2 | signal |
| 52 | Uveitis | 10 | 4.2 | 4.2 | signal |
| 53 | Accidental Overdose | 27 | 4.2 | 4.2 | signal |
| 54 | Therapy Partial Responder | 11 | 4.1 | 4.1 | signal |
| 55 | Cyst | 9 | 4.1 | 4.1 | signal |
| 56 | Malnutrition | 8 | 4.1 | 4.1 | signal |
| 57 | Vitamin D Deficiency | 7 | 4.1 | 4.1 | signal |
| 58 | Skin Infection | 8 | 4.1 | 4.1 | signal |
| 59 | Haemorrhoids | 14 | 4.0 | 4.1 | signal |
| 60 | Conjunctivitis | 13 | 4.0 | 4.0 | signal |
| 61 | Mitral Valve Incompetence | 8 | 4.0 | 4.0 | signal |
| 62 | Blood Alkaline Phosphatase Increased | 17 | 3.9 | 3.9 | signal |
| 63 | Hyperbilirubinaemia | 7 | 3.8 | 3.8 | signal |
| 64 | Quality Of Life Decreased | 9 | 3.8 | 3.8 | signal |
| 65 | Glomerular Filtration Rate Decreased | 8 | 3.7 | 3.7 | signal |
| 66 | Clostridium Difficile Colitis | 7 | 3.7 | 3.7 | signal |
| 67 | Hypoxia | 23 | 3.7 | 3.7 | signal |
| 68 | Haematocrit Decreased | 13 | 3.7 | 3.7 | signal |
| 69 | Secretion Discharge | 8 | 3.7 | 3.7 | signal |
| 70 | Oesophagitis | 7 | 3.6 | 3.6 | signal |
| 71 | Sleep Apnoea Syndrome | 12 | 3.5 | 3.6 | signal |
| 72 | Emotional Distress | 76 | 3.5 | 3.6 | signal |
| 73 | Skin Ulcer | 16 | 3.5 | 3.5 | signal |
| 74 | Scab | 7 | 3.5 | 3.5 | signal |
| 75 | Hiatus Hernia | 8 | 3.5 | 3.5 | signal |
| 76 | Blood Potassium Increased | 10 | 3.5 | 3.5 | signal |
| 77 | Leukocytosis | 11 | 3.4 | 3.4 | signal |
| 78 | Glycosylated Haemoglobin Increased | 15 | 3.4 | 3.4 | signal |
| 79 | Sinus Congestion | 8 | 3.3 | 3.3 | signal |
| 80 | Neck Pain | 33 | 3.3 | 3.4 | signal |
| 81 | Small Intestinal Obstruction | 7 | 3.2 | 3.2 | signal |
| 82 | Sinusitis | 58 | 3.2 | 3.2 | signal |
| 83 | Product Packaging Quantity Issue | 6 | 3.1 | 3.1 | signal |
| 84 | Deformity | 5 | 3.0 | 3.0 | signal |
| 85 | Type 2 Diabetes Mellitus | 18 | 3.0 | 3.0 | signal |
| 86 | Hip Fracture | 17 | 3.0 | 3.0 | signal |
| 87 | Impaired Driving Ability | 6 | 3.0 | 3.0 | signal |
| 88 | Red Blood Cell Count Decreased | 15 | 3.0 | 3.0 | signal |
| 89 | Pericardial Effusion | 12 | 2.9 | 3.0 | signal |
| 90 | Product Dose Omission Issue | 148 | 2.9 | 3.0 | signal |
| 91 | Oral Discomfort | 7 | 2.8 | 2.8 | signal |
| 92 | Respiratory Tract Congestion | 8 | 2.8 | 2.8 | signal |
| 93 | Carpal Tunnel Syndrome | 7 | 2.8 | 2.8 | signal |
| 94 | Wrong Technique In Product Usage Process | 99 | 2.8 | 2.8 | signal |
| 95 | Temperature Intolerance | 5 | 2.8 | 2.8 | signal |
| 96 | Coagulopathy | 8 | 2.7 | 2.7 | signal |
| 97 | Nasal Congestion | 28 | 2.7 | 2.7 | signal |
| 98 | Proteinuria | 9 | 2.7 | 2.7 | signal |
| 99 | Infusion Site Pain | 6 | 2.7 | 2.7 | signal |
| 100 | Hypoaesthesia Oral | 7 | 2.6 | 2.6 | signal |
| 101 | Body Height Decreased | 5 | 2.6 | 2.6 | no signal |
| 102 | Platelet Count Increased | 6 | 2.6 | 2.6 | signal |
| 103 | Gastrointestinal Pain | 5 | 2.6 | 2.6 | no signal |
| 104 | Multi-organ Failure | 8 | 2.6 | 2.6 | signal |
| 105 | Blood Triglycerides Increased | 8 | 2.5 | 2.6 | signal |
| 106 | Skin Disorder | 15 | 2.5 | 2.6 | signal |
| 107 | Oral Pain | 10 | 2.5 | 2.5 | signal |
| 108 | Increased Tendency To Bruise | 4 | 2.5 | 2.5 | no signal |
| 109 | Muscle Tightness | 7 | 2.4 | 2.4 | signal |
| 110 | Gastric Haemorrhage | 5 | 2.4 | 2.4 | no signal |
| 111 | Upper Gastrointestinal Haemorrhage | 7 | 2.3 | 2.3 | signal |
| 112 | Transient Ischaemic Attack | 14 | 2.3 | 2.3 | signal |
| 113 | Fluid Overload | 6 | 2.3 | 2.3 | no signal |
| 114 | Tooth Disorder | 9 | 2.3 | 2.3 | signal |
| 115 | Product Availability Issue | 9 | 2.3 | 2.3 | signal |
| 116 | Expired Product Administered | 13 | 2.2 | 2.2 | signal |
| 117 | Rotator Cuff Syndrome | 5 | 2.2 | 2.2 | no signal |
| 118 | Complication Associated With Device | 5 | 2.1 | 2.1 | no signal |
| 119 | Sars-cov-2 Test Positive | 5 | 2.1 | 2.1 | no signal |
| 120 | Pharyngitis Streptococcal | 4 | 2.1 | 2.1 | no signal |
| 121 | Hypoacusis | 15 | 2.0 | 2.0 | no signal |
| 122 | Anosmia | 5 | 1.9 | 1.9 | no signal |
| 123 | Intentional Product Misuse | 29 | 1.9 | 1.9 | no signal |
| 124 | Product Packaging Issue | 3 | 1.8 | 1.8 | no signal |
| 125 | Acute Myeloid Leukaemia | 5 | 1.8 | 1.8 | no signal |
| 126 | Dry Skin | 42 | 1.8 | 1.8 | no signal |
| 127 | Leukaemia | 3 | 1.8 | 1.8 | no signal |
| 128 | Hospitalisation | 48 | 1.8 | 1.8 | no signal |
| 129 | Inappropriate Schedule Of Drug Administration | 22 | 1.7 | 1.7 | no signal |
| 130 | Full Blood Count Decreased | 6 | 1.7 | 1.7 | no signal |
| 131 | Helicobacter Infection | 3 | 1.7 | 1.7 | no signal |
| 132 | Surgery | 17 | 1.7 | 1.7 | no signal |
| 133 | Drug Toxicity | 4 | 1.6 | 1.6 | no signal |
| 134 | Product Odour Abnormal | 3 | 1.6 | 1.6 | no signal |
| 135 | Product Storage Error | 25 | 1.6 | 1.6 | no signal |
| 136 | Neurotoxicity | 5 | 1.6 | 1.6 | no signal |
| 137 | Blood Glucose Increased | 52 | 1.6 | 1.6 | no signal |
| 138 | Pelvic Pain | 5 | 1.6 | 1.6 | no signal |
| 139 | Lactic Acidosis | 8 | 1.4 | 1.4 | no signal |
| 140 | Blood Glucose Decreased | 12 | 1.4 | 1.4 | no signal |
| 141 | Peritonitis | 5 | 1.4 | 1.4 | no signal |
| 142 | Product Taste Abnormal | 3 | 1.3 | 1.3 | no signal |
| 143 | Product Administered At Inappropriate Site | 4 | 1.2 | 1.2 | no signal |
| 144 | Multiple Sclerosis | 10 | 1.2 | 1.2 | no signal |
| 145 | Product Quality Issue | 28 | 1.2 | 1.2 | no signal |
| 146 | Injection Site Haematoma | 3 | 1.2 | 1.2 | no signal |
| 147 | Product Complaint | 5 | 1.1 | 1.1 | no signal |
| 148 | Accidental Exposure To Product | 18 | 1.0 | 1.0 | no signal |
| 149 | Drug Dose Omission | 29 | 1.0 | 1.0 | no signal |
| 150 | Exposure Via Skin Contact | 3 | 0.7 | 0.7 | no signal |
| 151 | Device Difficult To Use | 8 | 0.7 | 0.7 | no signal |
| 152 | Wrong Technique In Device Usage Process | 3 | 0.4 | 0.4 | no signal |